Replies to post #74905 on Innovation Pharmaceuticals Inc (IPIX)

[noretreat]

We don't know any of the actual numbers yet, and a more muted response from the market is to be expected until more results are available. These dosages seem to have worked at least as well as the dosages in the p2a, and they are within the (rather wide) range of statistical parity with Daptomycin.

All good results...but many questions remain. As soon as there is some actual data, I can give you the probabilities of success in the larger p3 trial, where the ranges tighten.

[cabel]

So knowing this maybe the big pop will come when the secondary outcomes are PR'd.


Have Leo and Dr Menon seen the secondary data yet,.. for they have decided to use one dose for Phase 3 already,....?

[cabel]

Any idea how much longer to get the rest of the info,... secondary data info,...days,... weeks,... months,...?

[58nout]

TOB, you said:

PR was definitely a bit rushed

So Leo might just be an idiot. We'll see.

GO CTIX